Maria Bartiromo shared a behind-the-scenes look at a high-profile night out on Thursday, January 29, posting a series of Instagram photos from a packed theater screening in New York City. The Fox ...

Fox Business anchor Maria Bartiromo pressed senior Trump trade advisor Peter Navarro after he urged investors to “revise expectations down significantly” ahead of Wednesday’s job report, arguing any ...

White House press secretary Karoline Leavitt told Maria Bartiromo on FNC's "Sunday Morning Futures" that the DOJ and FBI are closing in on "organized crime rings of leftist agitators" who are leading ...

Tim Allen and Jay Leno revisit Jay’s iconic Pontiac Firebird featured on Shifting Gears. As Jay shares the story behind the ...

Jay Leno was back in the driver’s seat — taking his antique wheels for a spin through the streets of Los Angeles. The Beverly Hills funnyman and former “Tonight Show” host, 75, was spotted cruising ...

Add Yahoo as a preferred source to see more of our stories on Google. Rep. Carlos Gimenez (R-TX) expressed confidence Monday that the House of Representatives would pass the Republican spending bill ...

WGN Radio personality Dave Plier sits down with late-night television legend Jay Leno for an engaging and deeply personal conversation you won’t want to miss. Featured prominently in The Evolution of ...

Jay Leno has driven and ridden just about everything with wheels. His YouTube channel, Jay Leno's Garage, is one of the most popular review sites on the internet. So when the crew at Slate wanted to ...

Sen. John Fetterman (D-Pa.) on Sunday said he “absolutely” expects a partial government shutdown amid the funding battle over the Department of Homeland Security (DHS). “I absolutely would expect that ...

WGN Radio’s Dave Plier sits down with late-night TV legend Jay Leno for a wide-ranging conversation about his remarkable career and personal journey. Jay reflects on the early days of his stand-up ...

A breakthrough personalized mRNA cancer vaccine that trains the immune system to target patients' unique tumor mutations is showing promising results. Five-year trial data show the risk of recurrence ...